Saba Kadlec

Executive Director of Clinical Development @Aurion Biotech

Milwaukee, WI, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jun 2025 — Present

Executive Director of Clinical Development @Aurion Biotech

View department →

Cambridge, MA, US

Aurion is paving the way with Endothelial Cell Therapy treatment for corneal endothelial diseases. As Executive Director of Clinical Development, I will be overseeing the strategic planning, execution, and management of our clinical trials as we advance from phase 1/2 to phase 3 trials. I am thrilled and honored to help bring this technology to subjects world-wide.

EDUCATION

2007 — 2010

University of Illinois College of Medicine

Ophthalmology Residency Program

2006 — 2007

NorthShore University Health

Internship

1998 — 2002

University of Illinois Urbana-Champaign

Bachelor of Science - BS, Biology

2002 — 2006

Rosalind Franklin University of Medicine and Science

Doctor of Medicine - MD

2010 — 2011

University of Illinois College of Medicine

Fellowship - Corneal external disease and refractive surgery

ABOUT SABA KADLEC

I am a clinical development specialist with 10+ years of experience as a practicing ophthalmologist, that was preceded by a fellowship in corneal external disease and refractive surgery from the Illinois Eye & Ear Infirmary. I have always been passionate about innovation and adoption of new technology, and feel fortunate to now be working at some of the most exciting companies in the eye care industry. While my clinical specialty was corneal surgery, my industry experience includes both anterior and posterior eye disease. In industry roles, I have been responsible for designing, executing, and overseeing the clinical trials, as well as collaborating with internal and external stakeholders, regulatory agencies, and investigators. Currently I am working as a Consultant at Aurion Biotech, supporting clinical development, surgeon training, and clinical affairs as well as for Opthea, supporting clinical development and safety monitoring of their phase Shore study.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.